Skip to Content

VIRACEPT 250 mg (Viracept 250 mg)

Generic Name: nelfinavir

Pill imprint VIRACEPT 250 mg has been identified as Viracept 250 mg.

Viracept is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Viracept 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Viracept 250 mg VIRACEPT 250 mg
Viracept 250 mg VIRACEPT 250 mg
Viracept 250 mg VIRACEPT 250 mg Front
Viracept 250 mg VIRACEPT 250 mg Back
Viracept
Generic Name:
nelfinavir
Imprint:
VIRACEPT 250 mg
Strength:
250 mg
Color:
Blue
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
ViiV Healthcare
National Drug Code (NDC):
63010-0010
Inactive Ingredients:
calcium silicate
crospovidone
magnesium stearate
hypromelloses
triacetin
FD&C Blue No. 2
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-3947 Physicians Total Care Inc (repackager)
55289-0477 PDRX Pharmaceuticals Inc (repackager)
54569-4543 A-S Medication Solutions, LLC (repackager)
52959-0289 H.J. Harkins Company, Inc (repackager)
49999-0431 Lake Erie Medical and Surgical Supply (repackager)
66267-0514 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide